{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:45:08Z","timestamp":1788871508528,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.mayocp.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T00:19:54Z","timestamp":1341188394000},"page":"659-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["My Treatment Approach to Rheumatoid Arthritis"],"prefix":"10.1016","volume":"87","author":[{"suffix":"III","given":"John M.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.011_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.23538","article-title":"Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US","volume":"59","author":"Allaire","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib4","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/ar2951","article-title":"Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study","volume":"12","author":"Sokka","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib5","first-page":"62","article-title":"Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis","volume":"29","author":"Turesson","year":"2002","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.2010.143396","article-title":"The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study","volume":"70","author":"Lindhardsen","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib8","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1136\/ard.2009.126128","article-title":"Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study [published online ahead of print June 15, 2010]","volume":"69","author":"Semb","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/art.21560","article-title":"Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis","volume":"54","author":"Nicola","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.mayocp.2012.03.011_bib12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force [published correction appears in Ann Rheum Dis. 2011;70(8):1519] [published online ahead of print March 9, 2010]","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2012.03.011_bib15","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/art.27580","article-title":"The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report","volume":"62","author":"Neogi","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2006.063792","article-title":"Magnetic resonance imaging and bone scintigraphy in the differential diagnosis of unclassified arthritis","volume":"67","author":"Duer","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semarthrit.2007.10.012","volume":"38","author":"Narv\u00e1ez","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.mayocp.2012.03.011_bib18","first-page":"1760","article-title":"Magnetic resonance imaging of the hand for the diagnosis of rheumatoid arthritis in the absence of anti-cyclic citrullinated peptide antibodies: a prospective study","volume":"33","author":"Solau-Gervais","year":"2006","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib19","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar1904","article-title":"Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination [published online ahead of print March 6, 2008]","volume":"8","author":"Szkudlarek","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.011_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2418","article-title":"The need for prognosticators in rheumatoid arthritis","volume":"10","author":"Smolen","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.mayocp.2012.03.011_bib22","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3899\/jrheum.081188","article-title":"Which measure of inflammation to use?","volume":"36","author":"Crowson","year":"2009","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.mayocp.2012.03.011_bib23","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/ard.2008.091801","article-title":"Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage","volume":"68","author":"Haavardsholm","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/ard.2008.097683","article-title":"DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis","volume":"69","author":"Goekoop-Ruiterman","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2011-200274","article-title":"A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry","volume":"71","author":"Schipper","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2012.03.011_bib26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","article-title":"Validation of rheumatoid arthritis improvement criteria that include simplified joint counts","volume":"41","author":"van Gestel","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"Wells","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2007.02.004","article-title":"The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care","volume":"21","author":"Aletaha","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.rdc.2009.10.006","article-title":"The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical care","volume":"35","author":"Aletaha","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"10.1016\/j.mayocp.2012.03.011_bib31","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/art.23794","article-title":"Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries","volume":"58","author":"Sokka","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.23247","article-title":"Clinical remission and\/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study","volume":"59","author":"Burmester","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/rheumatology\/kep442","article-title":"Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard","volume":"49","author":"Balsa","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2009.123976","article-title":"Evidence for treating rheumatoid arthritis to target: results of a systematic literature search [published correction appears in Ann Rheum Dis. 2011;70(8):1519]","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9164","key":"10.1016\/j.mayocp.2012.03.011_bib35","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0140-6736(98)08513-4","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial","volume":"353","author":"M\u00f6tt\u00f6nen","year":"1999","journal-title":"Lancet"},{"issue":"9430","key":"10.1016\/j.mayocp.2012.03.011_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"issue":"9636","key":"10.1016\/j.mayocp.2012.03.011_bib37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","article-title":"Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial","volume":"372","author":"Emery","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib38","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/ard.2007.071092","article-title":"Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)","volume":"66","author":"Verstappen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.011_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/art.30129","article-title":"American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"63","author":"Felson","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib40","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2008.090019","volume":"68","author":"Smolen","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.011_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.30199","article-title":"To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritis","volume":"63","author":"O'Dell","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2012.03.011_bib42","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/art.23439","article-title":"Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies","volume":"58","author":"de Vries-Bouwstra","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.27758","volume":"63","author":"Saevarsdottir","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2012.03.011_bib44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/ard.2005.039172","article-title":"Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis","volume":"65","author":"Nyh\u00e4ll-W\u00e5hlin","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib45","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/rheumatology\/kei240","article-title":"The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis","volume":"45","author":"Manfredsdottir","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib46","first-page":"861","article-title":"Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients?","volume":"23","author":"Papadopoulos","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.mayocp.2012.03.011_bib47","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/ard.2009.121160","article-title":"A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study","volume":"69","author":"Visser","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2012.03.011_bib48","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/kep155","article-title":"A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis","volume":"48","author":"Vastesaeger","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.011_bib49","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s10067-007-0615-0","article-title":"Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial","volume":"26","author":"Masiero","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.011_bib50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.semarthrit.2010.04.001","article-title":"A randomized trial of three psychosocial treatments for the symptoms of rheumatoid arthritis","volume":"40","author":"Barsky","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.011_bib51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/ard.2008.094532","article-title":"Early occupational therapy programme increases hand grip strength at 3 months: results from a randomised, blind, controlled study in early rheumatoid arthritis","volume":"68","author":"Mathieux","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pec.2010.02.014","article-title":"Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis: a randomized controlled trial","volume":"82","author":"Niedermann","year":"2011","journal-title":"Patient Educ Couns"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib53","article-title":"Occupational therapy for rheumatoid arthritis","author":"Steultjens","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib54","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/ard.2010.144691","article-title":"Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy","volume":"70","author":"Hewlett","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib55","article-title":"Dynamic exercise programs (aerobic capacity and\/or muscle strength training) in patients with rheumatoid arthritis","author":"Hurkmans","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.011_bib56","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/art.24891","article-title":"Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial","volume":"61","author":"Lemmey","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.mayocp.2012.03.011_bib57","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib58","article-title":"Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis","author":"Katchamart","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","article-title":"Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial","volume":"146","author":"Goekoop-Ruiterman","year":"2007","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib61","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib62","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","article-title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial","volume":"50","author":"St Clair","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib63","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/ard.2010.145268","article-title":"Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes","volume":"70","author":"Bathon","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.011_bib64","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/ard.2008.101121","article-title":"Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors","volume":"68","author":"Westhovens","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"suppl 10","key":"10.1016\/j.mayocp.2012.03.011_bib65","first-page":"S568","article-title":"Two-year radiographic results from the TEAR trial [abstract]","volume":"62","author":"Moreland","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"suppl 10","key":"10.1016\/j.mayocp.2012.03.011_bib66","first-page":"S1895","article-title":"TEAR: Treatment of Early Aggressive Rheumatoid Arthritis: a randomized, double-blind, 2-year trial comparing immediate triple DMARD versus MTX plus etanercept to step-up from initial MTX monotherapy [abstract]","volume":"60","author":"Moreland","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.mayocp.2012.03.011_bib67","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3899\/jrheum.090838","article-title":"Predictors of clinical response and radiographic progression in patients with rheumatoid arthritis treated with methotrexate monotherapy","volume":"37","author":"Drouin","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.mayocp.2012.03.011_bib68","first-page":"36","article-title":"The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: a metaanalysis of randomized controlled trials","volume":"25","author":"Ortiz","year":"1998","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/art.10083","article-title":"COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention","volume":"46","author":"Landew\u00e9","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib70","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/art.21298","article-title":"Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial","volume":"52","author":"Svensson","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2012.03.011_bib71","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-156-5-201203060-00004","article-title":"Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial","volume":"156","author":"Bakker","year":"2012","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.mayocp.2012.03.011_bib72","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.22943","article-title":"Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients","volume":"56","author":"Aletaha","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib73","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/ard.2010.137695","article-title":"Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort","volume":"70","author":"Soubrier","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2012.03.011_bib74","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/ard.2006.066662","article-title":"Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score","volume":"66","author":"van der Kooij","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"9688","key":"10.1016\/j.mayocp.2012.03.011_bib75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(09)60944-2","article-title":"Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial","volume":"374","author":"van Vollenhoven","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib76","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/art.10308","article-title":"Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes","volume":"46","author":"Genovese","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"9410","key":"10.1016\/j.mayocp.2012.03.011_bib77","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"issue":"9194","key":"10.1016\/j.mayocp.2012.03.011_bib78","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.011_bib79","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial","volume":"144","author":"Kremer","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.011_bib80","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar3060","article-title":"Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial","volume":"12","author":"Rantalaiho","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.mayocp.2012.03.011_bib81","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3899\/jrheum.091131","article-title":"Remission in early rheumatoid arthritis","volume":"37","author":"Ma","year":"2010","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib82","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa050524","article-title":"Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition [published correction appears in N Engl J Med. 2005;353(21):2311]","volume":"353","author":"Genovese","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.mayocp.2012.03.011_bib83","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/ard.2007.080002","article-title":"Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate","volume":"67","author":"Schiff","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"9685","key":"10.1016\/j.mayocp.2012.03.011_bib84","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(09)60506-7","volume":"374","author":"Smolen","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.mayocp.2012.03.011_bib85","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/ard.2006.068304","article-title":"Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the OPPOSITE study","volume":"66","author":"Furst","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2012.03.011_bib86","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.mayocp.2012.03.011_bib87","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9617","key":"10.1016\/j.mayocp.2012.03.011_bib88","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib89","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","volume":"67","author":"Emery","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.03.011_bib90","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/art.30233","article-title":"B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study","volume":"63","author":"Sellam","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib91","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.2010.136556","article-title":"Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study","volume":"70","author":"Klarenbeek","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.mayocp.2012.03.011_bib92","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.24661","article-title":"Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts","volume":"60","author":"van der Woude","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.mayocp.2012.03.011_bib93","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/ard.2009.117341","article-title":"Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?","volume":"69","author":"Saleem","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2012.03.011_bib94","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.mayocp.2012.03.011_bib95","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis [published correction appears in Arthritis Care Res (Hoboken). 2012;64(1):157; author reply 157-158]","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.011_bib96","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/rheumatology\/keh322","article-title":"The DAS28 in rheumatoid arthritis and fibromyalgia patients","volume":"43","author":"Leeb","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.mayocp.2012.03.011_bib97","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/art.23945","article-title":"An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis","volume":"58","author":"Brown","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.mayocp.2012.03.011_bib98","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.22190","article-title":"Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression","volume":"54","author":"Brown","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.mayocp.2012.03.011_bib99","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/ard.2009.125534","article-title":"Radiographic progression and remission rates in early rheumatoid arthritis: MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial","volume":"69","author":"Hetland","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2012.03.011_bib100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/ard.2008.088245","article-title":"MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis: results from a 2 year randomized controlled trial (CIMESTRA)","volume":"68","author":"Hetland","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.03.011_bib101","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/acr.20132","article-title":"Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis","volume":"62","author":"Barton","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612004727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612004727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:27:48Z","timestamp":1758418068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619612004727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":101,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0025619612004727"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.03.011","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"My Treatment Approach to Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}